Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

In the latest close session, CRISPR Therapeutics AG (CRSP) was down 5.44% at $49.93. This move lagged the S&P 500's daily loss of 0.08%. On the other hand, the Dow registered a loss of 0.61%, and the ...

They're names worth holding for far longer, but the coming decade could prove particularly fruitful for these companies.

CRISPR Therapeutics AG (NASDAQ: CRSP) is one of the 10 most shorted biotech stocks to buy according to hedge funds. On February 17, Morgan Stanley increased its price target on CRISPR Therapeutics AG ...

This article looks at the ARK Invest Stock Portfolio: Top 10 Stock Picks for 2026. ARK Investment Management LLC, or ARK Invest, is an American investment management firm that oversees several ...

Celestica has delivered strong revenue and EPS growth, driven by AI and cloud infrastructure demand. Click here to read why ...

Browse investing articles and stock analysis by James Halley. Get expert financial insights and investment advice from The Motley Fool.

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today reported financial ...

Tuesday’s market has seen swings in various stocks based on news and other factors. Today, stocks like Micron Tech and NIO are rallying, while stocks like Palantir Technologies ...